Cargando…

Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database

BACKGROUND: Biological therapies (BTs) including infliximab (IFX), adalimumab (ADL), secukinumab (SCK) and ustekinumab (UST) are approved in Japan for the treatment of psoriasis. Although the persistence rates and medical costs of BTs treatment have been investigated in multiple foreign studies in r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sruamsiri, Rosarin, Iwasaki, Kosuke, Tang, Wentao, Mahlich, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042444/ https://www.ncbi.nlm.nih.gov/pubmed/29996929 http://dx.doi.org/10.1186/s12895-018-0074-0

Ejemplares similares

Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
por: Mahlich, Jörg, et al.
Publicado: (2016)

Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs
por: Sruamsiri, Rosarin, et al.
Publicado: (2018)

Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study
por: Miyazaki, Celine, et al.
Publicado: (2020)

The underrated prevalence of depression in Japanese patients with rheumatoid arthritis - evidence from a Nationwide survey in Japan
por: Sruamsiri, Rosarin, et al.
Publicado: (2017)

Biologic treatment of Japanese patients with inflammatory bowel disease
por: Mahlich, Jörg, et al.
Publicado: (2018)

Hospitalization costs and length of stay of Japanese children with respiratory syncytial virus: A structural equation modeling approach
por: Sruamsiri, Rosarin, et al.
Publicado: (2018)

Co-insurance and health care utilization in Japanese patients with rheumatoid arthritis: a discontinuity regression approach
por: Mahlich, Jörg, et al.
Publicado: (2019)

Shared Decision-Making and Patient Satisfaction in Japanese Rheumatoid Arthritis Patients: A New “Preference Fit” Framework for Treatment Assessment
por: Mahlich, Jörg, et al.
Publicado: (2019)

Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis
por: Cheung, Stephane, et al.
Publicado: (2017)

Cultural beliefs, utility values, and health technology assessment
por: Mahlich, Jörg, et al.
Publicado: (2018)

Impact of patient characteristics and treatment procedures on hospitalization cost and length of stay in Japanese patients with influenza: A structural equation modelling approach
por: Sruamsiri, Rosarin, et al.
Publicado: (2017)

Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients
por: Morishige, Ryuji, et al.
Publicado: (2016)

Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study
por: Mahlich, Jörg, et al.
Publicado: (2017)

Real-World Treatment Persistence with Biologic Disease-Modifying Antirheumatic Drugs Among German Patients with Psoriatic Arthritis—A Retrospective Database Study
por: Sewerin, Philipp, et al.
Publicado: (2021)

Treatment Status and Healthcare Cost Trends for Patients with Multiple Sclerosis in Japan: A Claims Database Analysis
por: Kawachi, Izumi, et al.
Publicado: (2022)

Persistence With Biologic Therapy and Associated Costs of Patients With Inflammatory Bowel Disease: A German Retrospective Claims Data Analysis
por: Mahlich, Joerg, et al.
Publicado: (2021)

A Real-World Claims Database Study Assessing Long-Term Persistence with Golimumab Treatment in Patients with Rheumatoid Arthritis in Japan
por: Miyashiro, Masahiko, et al.
Publicado: (2023)

Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database
por: Ogino, Mieko, et al.
Publicado: (2017)

Real‐world burden and treatment of chronic rhinosinusitis in Japan: A retrospective claims database analysis
por: Yoshikawa, Mamoru, et al.
Publicado: (2023)

Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis
por: Kondoh, Yasuhiro, et al.
Publicado: (2022)

Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan
por: Bolt, Timothy, et al.
Publicado: (2018)

Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims database
por: Kawachi, Izumi, et al.
Publicado: (2019)

Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan(®) Databases
por: Leonardi, Craig, et al.
Publicado: (2022)

The relationship between socio-demographic factors, health status, treatment type, and employment outcome in patients with inflammatory bowel disease in Japan
por: Mahlich, J, et al.
Publicado: (2017)

Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai—A claims database study
por: Al Dallal, Sara Ahmad Mohammad, et al.
Publicado: (2021)

Real-world evidence of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer using an administrative claims database in Japan
por: Kagawa, Y., et al.
Publicado: (2023)

S107. HEALTHCARE UTILIZATION AND COST IN SCHIZOPHRENIA AND BIPOLAR DISORDER: REAL-WORLD EVIDENCE FROM US CLAIMS DATABASES
por: Greene, Mallik, et al.
Publicado: (2018)

Epidemiology and costs of dengue in Thailand: A systematic literature review
por: Thisyakorn, Usa, et al.
Publicado: (2022)

Treatment patterns, healthcare resource utilization, and costs in patients with moderate‐to‐severe psoriasis treated with systemic therapy in Japan: A retrospective claims database study
por: Tada, Yayoi, et al.
Publicado: (2022)

Current treatment status and medical cost for multiple sclerosis based on analysis of a Japanese claims database
por: Ogino, Mieko, et al.
Publicado: (2016)

Real-World Prescription Pattern and Healthcare Cost Among Patients with Ulcerative Colitis in Japan: A Retrospective Claims Data Analysis
por: Miyazaki, Celine, et al.
Publicado: (2021)

Real-World Epidemiology, Clinical and Economic Burden of Chronic Hepatitis B in Japan: A Retrospective Study Using JMDC Claims Database
por: Umemura, Takeji, et al.
Publicado: (2023)

Persistence and treatment patterns of fixed combination drugs for glaucoma: a retrospective claims database study in Japan
por: Kashiwagi, Kenji, et al.
Publicado: (2020)

Relationship Between the Number of Occlusal Supporting and Medical Cost: Analysis Using Large Claims Database from Employee Health Care Insurance in Japan
por: Murata, Tatsunori, et al.
Publicado: (2020)

Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data
por: Kuwabara, Hiroyo, et al.
Publicado: (2015)

Real-world treatment patterns of gastrointestinal neuroendocrine tumors: A claims database analysis
por: Benson III, Al B, et al.
Publicado: (2017)

Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database
por: Calapai, Fabrizio, et al.
Publicado: (2023)

Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis
por: Sruamsiri, Rosarin, et al.
Publicado: (2016)

Quality of Reporting of Randomised Controlled Trials of Herbal Interventions in ASEAN Plus Six Countries: A Systematic Review
por: Pratoomsoot, Chayanin, et al.
Publicado: (2015)

Correction to: Real-World Prescription Pattern and Healthcare Cost Among Patients with Ulcerative Colitis in Japan: A Retrospective Claims Data Analysis
por: Miyazaki, Celine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pts3eh5kh6cde9ij9mbt4kaakc